nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—Sensation of heat—Niacin—atherosclerosis	0.0219	0.0819	CcSEcCtD
Hydroxocobalamin—Cyanocobalamin—MTHFR—atherosclerosis	0.00966	1	CrCbGaD
Hydroxocobalamin—TCN2—connective tissue—atherosclerosis	0.00636	0.065	CbGeAlD
Hydroxocobalamin—MMACHC—liver—atherosclerosis	0.00611	0.0624	CbGeAlD
Hydroxocobalamin—CUBN—adipose tissue—atherosclerosis	0.00604	0.0617	CbGeAlD
Hydroxocobalamin—Memory impairment—Rosuvastatin—atherosclerosis	0.00592	0.0222	CcSEcCtD
Hydroxocobalamin—MMAA—adipose tissue—atherosclerosis	0.00571	0.0583	CbGeAlD
Hydroxocobalamin—MMAB—adipose tissue—atherosclerosis	0.00535	0.0547	CbGeAlD
Hydroxocobalamin—AMN—liver—atherosclerosis	0.00503	0.0514	CbGeAlD
Hydroxocobalamin—Memory impairment—Lovastatin—atherosclerosis	0.00502	0.0188	CcSEcCtD
Hydroxocobalamin—Redness—Niacin—atherosclerosis	0.00501	0.0188	CcSEcCtD
Hydroxocobalamin—MUT—connective tissue—atherosclerosis	0.005	0.0511	CbGeAlD
Hydroxocobalamin—CASP9—adipose tissue—atherosclerosis	0.005	0.0511	CbGeAlD
Hydroxocobalamin—Memory impairment—Ezetimibe—atherosclerosis	0.00492	0.0184	CcSEcCtD
Hydroxocobalamin—TCN2—adipose tissue—atherosclerosis	0.00488	0.0499	CbGeAlD
Hydroxocobalamin—Lung disorder—Niacin—atherosclerosis	0.00478	0.0179	CcSEcCtD
Hydroxocobalamin—Memory impairment—Simvastatin—atherosclerosis	0.00469	0.0176	CcSEcCtD
Hydroxocobalamin—MTRR—connective tissue—atherosclerosis	0.0045	0.0459	CbGeAlD
Hydroxocobalamin—MUT—cardiovascular system—atherosclerosis	0.00435	0.0445	CbGeAlD
Hydroxocobalamin—Feeling hot—Niacin—atherosclerosis	0.00431	0.0161	CcSEcCtD
Hydroxocobalamin—Memory impairment—Pravastatin—atherosclerosis	0.00424	0.0159	CcSEcCtD
Hydroxocobalamin—MMAA—liver—atherosclerosis	0.004	0.0409	CbGeAlD
Hydroxocobalamin—MTR—connective tissue—atherosclerosis	0.00392	0.0401	CbGeAlD
Hydroxocobalamin—MUT—adipose tissue—atherosclerosis	0.00384	0.0392	CbGeAlD
Hydroxocobalamin—MMAB—liver—atherosclerosis	0.00375	0.0384	CbGeAlD
Hydroxocobalamin—CASP9—liver—atherosclerosis	0.00351	0.0358	CbGeAlD
Hydroxocobalamin—MTRR—adipose tissue—atherosclerosis	0.00345	0.0352	CbGeAlD
Hydroxocobalamin—TCN2—liver—atherosclerosis	0.00342	0.035	CbGeAlD
Hydroxocobalamin—MTR—cardiovascular system—atherosclerosis	0.00341	0.0349	CbGeAlD
Hydroxocobalamin—Swelling—Simvastatin—atherosclerosis	0.00303	0.0114	CcSEcCtD
Hydroxocobalamin—MTR—adipose tissue—atherosclerosis	0.00301	0.0307	CbGeAlD
Hydroxocobalamin—Hot flush—Ezetimibe—atherosclerosis	0.003	0.0112	CcSEcCtD
Hydroxocobalamin—Eczema—Simvastatin—atherosclerosis	0.00298	0.0111	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Ezetimibe—atherosclerosis	0.00297	0.0111	CcSEcCtD
Hydroxocobalamin—Eczema—Niacin—atherosclerosis	0.00273	0.0102	CcSEcCtD
Hydroxocobalamin—MUT—liver—atherosclerosis	0.00269	0.0275	CbGeAlD
Hydroxocobalamin—Hot flush—Pravastatin—atherosclerosis	0.00258	0.00968	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Niacin—atherosclerosis	0.00257	0.00962	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Pravastatin—atherosclerosis	0.00256	0.0096	CcSEcCtD
Hydroxocobalamin—MTRR—liver—atherosclerosis	0.00242	0.0247	CbGeAlD
Hydroxocobalamin—Abdominal discomfort—Lovastatin—atherosclerosis	0.00237	0.00887	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Simvastatin—atherosclerosis	0.00222	0.0083	CcSEcCtD
Hydroxocobalamin—Dysphagia—Niacin—atherosclerosis	0.00212	0.00795	CcSEcCtD
Hydroxocobalamin—MTR—liver—atherosclerosis	0.00211	0.0216	CbGeAlD
Hydroxocobalamin—Arrhythmia—Rosuvastatin—atherosclerosis	0.00208	0.00781	CcSEcCtD
Hydroxocobalamin—Mental disorder—Rosuvastatin—atherosclerosis	0.00204	0.00766	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Ezetimibe—atherosclerosis	0.00191	0.00716	CcSEcCtD
Hydroxocobalamin—Angioedema—Rosuvastatin—atherosclerosis	0.00186	0.00695	CcSEcCtD
Hydroxocobalamin—Chills—Lovastatin—atherosclerosis	0.00177	0.00665	CcSEcCtD
Hydroxocobalamin—Angiopathy—Ezetimibe—atherosclerosis	0.00176	0.00659	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Ezetimibe—atherosclerosis	0.00175	0.00656	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00175	0.00655	CcSEcCtD
Hydroxocobalamin—Mental disorder—Ezetimibe—atherosclerosis	0.0017	0.00636	CcSEcCtD
Hydroxocobalamin—Erythema—Ezetimibe—atherosclerosis	0.00169	0.00632	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Niacin—atherosclerosis	0.00167	0.00627	CcSEcCtD
Hydroxocobalamin—Chills—Simvastatin—atherosclerosis	0.00166	0.00622	CcSEcCtD
Hydroxocobalamin—Infection—Rosuvastatin—atherosclerosis	0.00165	0.00617	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00163	0.00609	CcSEcCtD
Hydroxocobalamin—Mental disorder—Simvastatin—atherosclerosis	0.00162	0.00607	CcSEcCtD
Hydroxocobalamin—Erythema—Simvastatin—atherosclerosis	0.00161	0.00603	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Lovastatin—atherosclerosis	0.0016	0.00598	CcSEcCtD
Hydroxocobalamin—Eye disorder—Niacin—atherosclerosis	0.00159	0.00595	CcSEcCtD
Hydroxocobalamin—Angioedema—Lovastatin—atherosclerosis	0.00157	0.00589	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00157	0.00587	CcSEcCtD
Hydroxocobalamin—Malaise—Lovastatin—atherosclerosis	0.00155	0.00581	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Pravastatin—atherosclerosis	0.00155	0.00581	CcSEcCtD
Hydroxocobalamin—Angioedema—Ezetimibe—atherosclerosis	0.00154	0.00578	CcSEcCtD
Hydroxocobalamin—Angiopathy—Niacin—atherosclerosis	0.00154	0.00577	CcSEcCtD
Hydroxocobalamin—Chills—Niacin—atherosclerosis	0.00152	0.00571	CcSEcCtD
Hydroxocobalamin—Malaise—Ezetimibe—atherosclerosis	0.00152	0.0057	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Niacin—atherosclerosis	0.00152	0.00568	CcSEcCtD
Hydroxocobalamin—Chills—Pravastatin—atherosclerosis	0.0015	0.00562	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Simvastatin—atherosclerosis	0.00149	0.0056	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Pravastatin—atherosclerosis	0.00149	0.0056	CcSEcCtD
Hydroxocobalamin—Erythema—Niacin—atherosclerosis	0.00148	0.00554	CcSEcCtD
Hydroxocobalamin—Angioedema—Simvastatin—atherosclerosis	0.00147	0.00551	CcSEcCtD
Hydroxocobalamin—Chest pain—Lovastatin—atherosclerosis	0.00147	0.00549	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Rosuvastatin—atherosclerosis	0.00146	0.00547	CcSEcCtD
Hydroxocobalamin—Malaise—Simvastatin—atherosclerosis	0.00145	0.00544	CcSEcCtD
Hydroxocobalamin—Discomfort—Lovastatin—atherosclerosis	0.00145	0.00542	CcSEcCtD
Hydroxocobalamin—Chest pain—Ezetimibe—atherosclerosis	0.00144	0.00538	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00143	0.00535	CcSEcCtD
Hydroxocobalamin—Discomfort—Ezetimibe—atherosclerosis	0.00142	0.00532	CcSEcCtD
Hydroxocobalamin—Pain—Rosuvastatin—atherosclerosis	0.00142	0.00531	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Lovastatin—atherosclerosis	0.00141	0.00526	CcSEcCtD
Hydroxocobalamin—Infection—Lovastatin—atherosclerosis	0.0014	0.00523	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00138	0.00516	CcSEcCtD
Hydroxocobalamin—Chest pain—Simvastatin—atherosclerosis	0.00137	0.00513	CcSEcCtD
Hydroxocobalamin—Infection—Ezetimibe—atherosclerosis	0.00137	0.00513	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00137	0.00512	CcSEcCtD
Hydroxocobalamin—Discomfort—Simvastatin—atherosclerosis	0.00135	0.00507	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Ezetimibe—atherosclerosis	0.00135	0.00506	CcSEcCtD
Hydroxocobalamin—Angioedema—Niacin—atherosclerosis	0.00135	0.00506	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Pravastatin—atherosclerosis	0.00135	0.00506	CcSEcCtD
Hydroxocobalamin—Skin disorder—Ezetimibe—atherosclerosis	0.00134	0.00501	CcSEcCtD
Hydroxocobalamin—Angioedema—Pravastatin—atherosclerosis	0.00133	0.00498	CcSEcCtD
Hydroxocobalamin—Urticaria—Rosuvastatin—atherosclerosis	0.00132	0.00493	CcSEcCtD
Hydroxocobalamin—Oedema—Simvastatin—atherosclerosis	0.00131	0.00492	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Simvastatin—atherosclerosis	0.00131	0.00492	CcSEcCtD
Hydroxocobalamin—Malaise—Pravastatin—atherosclerosis	0.00131	0.00492	CcSEcCtD
Hydroxocobalamin—Infection—Simvastatin—atherosclerosis	0.00131	0.00489	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Lovastatin—atherosclerosis	0.00125	0.00469	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00125	0.00468	CcSEcCtD
Hydroxocobalamin—Chest pain—Pravastatin—atherosclerosis	0.00124	0.00464	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Lovastatin—atherosclerosis	0.00124	0.00463	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Ezetimibe—atherosclerosis	0.00123	0.0046	CcSEcCtD
Hydroxocobalamin—Discomfort—Pravastatin—atherosclerosis	0.00122	0.00459	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00122	0.00457	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Ezetimibe—atherosclerosis	0.00121	0.00454	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Niacin—atherosclerosis	0.00121	0.00452	CcSEcCtD
Hydroxocobalamin—Oedema—Niacin—atherosclerosis	0.00121	0.00452	CcSEcCtD
Hydroxocobalamin—Pain—Lovastatin—atherosclerosis	0.0012	0.0045	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00119	0.00446	CcSEcCtD
Hydroxocobalamin—Oedema—Pravastatin—atherosclerosis	0.00119	0.00445	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Pravastatin—atherosclerosis	0.00119	0.00445	CcSEcCtD
Hydroxocobalamin—Infection—Pravastatin—atherosclerosis	0.00118	0.00442	CcSEcCtD
Hydroxocobalamin—Pain—Ezetimibe—atherosclerosis	0.00118	0.00441	CcSEcCtD
Hydroxocobalamin—Tachycardia—Niacin—atherosclerosis	0.00118	0.00441	CcSEcCtD
Hydroxocobalamin—Pruritus—Rosuvastatin—atherosclerosis	0.00117	0.00439	CcSEcCtD
Hydroxocobalamin—Skin disorder—Niacin—atherosclerosis	0.00117	0.00439	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Simvastatin—atherosclerosis	0.00117	0.00439	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Lovastatin—atherosclerosis	0.00116	0.00434	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Simvastatin—atherosclerosis	0.00116	0.00433	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Ezetimibe—atherosclerosis	0.00114	0.00425	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00113	0.00425	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Rosuvastatin—atherosclerosis	0.00113	0.00425	CcSEcCtD
Hydroxocobalamin—Pain—Simvastatin—atherosclerosis	0.00112	0.00421	CcSEcCtD
Hydroxocobalamin—Urticaria—Lovastatin—atherosclerosis	0.00112	0.00418	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Lovastatin—atherosclerosis	0.00111	0.00416	CcSEcCtD
Hydroxocobalamin—Dizziness—Rosuvastatin—atherosclerosis	0.0011	0.00411	CcSEcCtD
Hydroxocobalamin—Urticaria—Ezetimibe—atherosclerosis	0.00109	0.0041	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Ezetimibe—atherosclerosis	0.00109	0.00408	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Simvastatin—atherosclerosis	0.00108	0.00406	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Niacin—atherosclerosis	0.00108	0.00403	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Niacin—atherosclerosis	0.00106	0.00398	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Pravastatin—atherosclerosis	0.00106	0.00397	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Pravastatin—atherosclerosis	0.00105	0.00392	CcSEcCtD
Hydroxocobalamin—Rash—Rosuvastatin—atherosclerosis	0.00105	0.00392	CcSEcCtD
Hydroxocobalamin—Dermatitis—Rosuvastatin—atherosclerosis	0.00104	0.00391	CcSEcCtD
Hydroxocobalamin—Urticaria—Simvastatin—atherosclerosis	0.00104	0.00391	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Niacin—atherosclerosis	0.00104	0.0039	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Simvastatin—atherosclerosis	0.00104	0.00389	CcSEcCtD
Hydroxocobalamin—Headache—Rosuvastatin—atherosclerosis	0.00104	0.00389	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Lovastatin—atherosclerosis	0.00104	0.00388	CcSEcCtD
Hydroxocobalamin—Pain—Niacin—atherosclerosis	0.00103	0.00386	CcSEcCtD
Hydroxocobalamin—Pain—Pravastatin—atherosclerosis	0.00102	0.00381	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Ezetimibe—atherosclerosis	0.00102	0.0038	CcSEcCtD
Hydroxocobalamin—Pruritus—Lovastatin—atherosclerosis	0.000994	0.00372	CcSEcCtD
Hydroxocobalamin—Nausea—Rosuvastatin—atherosclerosis	0.000985	0.00369	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Pravastatin—atherosclerosis	0.000979	0.00367	CcSEcCtD
Hydroxocobalamin—Pruritus—Ezetimibe—atherosclerosis	0.000975	0.00365	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Simvastatin—atherosclerosis	0.000968	0.00363	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Lovastatin—atherosclerosis	0.000961	0.0036	CcSEcCtD
Hydroxocobalamin—Urticaria—Niacin—atherosclerosis	0.000959	0.00359	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Niacin—atherosclerosis	0.000954	0.00357	CcSEcCtD
Hydroxocobalamin—Urticaria—Pravastatin—atherosclerosis	0.000944	0.00354	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Ezetimibe—atherosclerosis	0.000943	0.00353	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Pravastatin—atherosclerosis	0.000939	0.00352	CcSEcCtD
Hydroxocobalamin—Pruritus—Simvastatin—atherosclerosis	0.00093	0.00348	CcSEcCtD
Hydroxocobalamin—Dizziness—Lovastatin—atherosclerosis	0.000929	0.00348	CcSEcCtD
Hydroxocobalamin—Dizziness—Ezetimibe—atherosclerosis	0.000911	0.00341	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Simvastatin—atherosclerosis	0.000899	0.00337	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Niacin—atherosclerosis	0.000889	0.00333	CcSEcCtD
Hydroxocobalamin—Rash—Lovastatin—atherosclerosis	0.000886	0.00332	CcSEcCtD
Hydroxocobalamin—Dermatitis—Lovastatin—atherosclerosis	0.000885	0.00331	CcSEcCtD
Hydroxocobalamin—Headache—Lovastatin—atherosclerosis	0.00088	0.0033	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Pravastatin—atherosclerosis	0.000875	0.00328	CcSEcCtD
Hydroxocobalamin—Dizziness—Simvastatin—atherosclerosis	0.000869	0.00325	CcSEcCtD
Hydroxocobalamin—Rash—Ezetimibe—atherosclerosis	0.000869	0.00325	CcSEcCtD
Hydroxocobalamin—Dermatitis—Ezetimibe—atherosclerosis	0.000868	0.00325	CcSEcCtD
Hydroxocobalamin—Headache—Ezetimibe—atherosclerosis	0.000863	0.00323	CcSEcCtD
Hydroxocobalamin—Pruritus—Niacin—atherosclerosis	0.000854	0.0032	CcSEcCtD
Hydroxocobalamin—Pruritus—Pravastatin—atherosclerosis	0.000841	0.00315	CcSEcCtD
Hydroxocobalamin—Nausea—Lovastatin—atherosclerosis	0.000835	0.00313	CcSEcCtD
Hydroxocobalamin—Rash—Simvastatin—atherosclerosis	0.000829	0.0031	CcSEcCtD
Hydroxocobalamin—Dermatitis—Simvastatin—atherosclerosis	0.000828	0.0031	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Niacin—atherosclerosis	0.000826	0.00309	CcSEcCtD
Hydroxocobalamin—Headache—Simvastatin—atherosclerosis	0.000823	0.00308	CcSEcCtD
Hydroxocobalamin—Nausea—Ezetimibe—atherosclerosis	0.000819	0.00307	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Pravastatin—atherosclerosis	0.000813	0.00304	CcSEcCtD
Hydroxocobalamin—Dizziness—Niacin—atherosclerosis	0.000798	0.00299	CcSEcCtD
Hydroxocobalamin—Dizziness—Pravastatin—atherosclerosis	0.000786	0.00294	CcSEcCtD
Hydroxocobalamin—Nausea—Simvastatin—atherosclerosis	0.000781	0.00292	CcSEcCtD
Hydroxocobalamin—Rash—Niacin—atherosclerosis	0.000761	0.00285	CcSEcCtD
Hydroxocobalamin—Dermatitis—Niacin—atherosclerosis	0.00076	0.00285	CcSEcCtD
Hydroxocobalamin—Headache—Niacin—atherosclerosis	0.000756	0.00283	CcSEcCtD
Hydroxocobalamin—Rash—Pravastatin—atherosclerosis	0.000749	0.00281	CcSEcCtD
Hydroxocobalamin—Dermatitis—Pravastatin—atherosclerosis	0.000748	0.0028	CcSEcCtD
Hydroxocobalamin—Headache—Pravastatin—atherosclerosis	0.000744	0.00279	CcSEcCtD
Hydroxocobalamin—Nausea—Niacin—atherosclerosis	0.000717	0.00268	CcSEcCtD
Hydroxocobalamin—Nausea—Pravastatin—atherosclerosis	0.000706	0.00264	CcSEcCtD
Hydroxocobalamin—MMAA—Metabolism—PPARG—atherosclerosis	4.37e-05	6.98e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PPARG—atherosclerosis	4.37e-05	6.98e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—APOA1—atherosclerosis	4.36e-05	6.98e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—AKT1—atherosclerosis	4.34e-05	6.94e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—APOE—atherosclerosis	4.33e-05	6.92e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—LPL—atherosclerosis	4.32e-05	6.91e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PIK3CG—atherosclerosis	4.32e-05	6.9e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CX3CL1—atherosclerosis	4.3e-05	6.88e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—AKT1—atherosclerosis	4.3e-05	6.88e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CAV1—atherosclerosis	4.29e-05	6.86e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—INS—atherosclerosis	4.28e-05	6.85e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—INS—atherosclerosis	4.28e-05	6.85e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—AKT1—atherosclerosis	4.28e-05	6.85e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—NOS3—atherosclerosis	4.28e-05	6.84e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—APOA1—atherosclerosis	4.28e-05	6.84e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—STAT3—atherosclerosis	4.22e-05	6.75e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—GPX1—atherosclerosis	4.22e-05	6.75e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—NOS3—atherosclerosis	4.21e-05	6.74e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—LPL—atherosclerosis	4.21e-05	6.73e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—IL6—atherosclerosis	4.2e-05	6.72e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PPARG—atherosclerosis	4.17e-05	6.66e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PTGS2—atherosclerosis	4.15e-05	6.63e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PTGS2—atherosclerosis	4.15e-05	6.63e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—SERPINE1—atherosclerosis	4.14e-05	6.61e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	4.12e-05	6.59e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD14—atherosclerosis	4.11e-05	6.58e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—CD36—atherosclerosis	4.11e-05	6.57e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PTGS2—atherosclerosis	4.1e-05	6.56e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PTGS2—atherosclerosis	4.1e-05	6.56e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PRKCG—atherosclerosis	4.09e-05	6.54e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—INS—atherosclerosis	4.09e-05	6.53e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CNR2—atherosclerosis	4.08e-05	6.52e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—AKT1—atherosclerosis	4.05e-05	6.48e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NOS2—atherosclerosis	4.03e-05	6.45e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—MAPK3—atherosclerosis	4.03e-05	6.45e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CG—atherosclerosis	3.98e-05	6.37e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—VCAM1—atherosclerosis	3.97e-05	6.35e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NOS3—atherosclerosis	3.95e-05	6.31e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—ALB—atherosclerosis	3.93e-05	6.28e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—ALB—atherosclerosis	3.93e-05	6.28e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTGS2—atherosclerosis	3.91e-05	6.26e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—TGFB1—atherosclerosis	3.91e-05	6.26e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—MTHFR—atherosclerosis	3.89e-05	6.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—AKT1—atherosclerosis	3.88e-05	6.2e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—STAT3—atherosclerosis	3.86e-05	6.17e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—STAT3—atherosclerosis	3.86e-05	6.17e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTGS2—atherosclerosis	3.85e-05	6.16e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—HMOX1—atherosclerosis	3.85e-05	6.16e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—SOCS3—atherosclerosis	3.85e-05	6.16e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PPARG—atherosclerosis	3.85e-05	6.15e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PPARA—atherosclerosis	3.82e-05	6.11e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MTHFR—atherosclerosis	3.79e-05	6.06e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—INS—atherosclerosis	3.77e-05	6.03e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—NOS3—atherosclerosis	3.76e-05	6.01e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—NOS3—atherosclerosis	3.76e-05	6.01e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—ALB—atherosclerosis	3.75e-05	5.99e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AGT—atherosclerosis	3.7e-05	5.92e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—INS—atherosclerosis	3.7e-05	5.91e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—APOB—atherosclerosis	3.69e-05	5.9e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—MAPK3—atherosclerosis	3.69e-05	5.9e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—MAPK3—atherosclerosis	3.69e-05	5.9e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PDGFB—atherosclerosis	3.69e-05	5.9e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VWF—atherosclerosis	3.64e-05	5.82e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—APOE—atherosclerosis	3.63e-05	5.8e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APOC3—atherosclerosis	3.61e-05	5.78e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTGS2—atherosclerosis	3.61e-05	5.77e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—LDLR—atherosclerosis	3.59e-05	5.74e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—CAV1—atherosclerosis	3.59e-05	5.74e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GSTM1—atherosclerosis	3.59e-05	5.74e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—STAT3—atherosclerosis	3.59e-05	5.74e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—NOS3—atherosclerosis	3.58e-05	5.73e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—APOA1—atherosclerosis	3.58e-05	5.73e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—TGFB1—atherosclerosis	3.58e-05	5.72e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—TGFB1—atherosclerosis	3.58e-05	5.72e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—APOE—atherosclerosis	3.53e-05	5.64e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—LPL—atherosclerosis	3.53e-05	5.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL18—atherosclerosis	3.51e-05	5.61e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCL3—atherosclerosis	3.51e-05	5.61e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD40LG—atherosclerosis	3.5e-05	5.59e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CAV1—atherosclerosis	3.5e-05	5.59e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—APOA1—atherosclerosis	3.49e-05	5.58e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—ALB—atherosclerosis	3.46e-05	5.53e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GPX1—atherosclerosis	3.44e-05	5.5e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTGS2—atherosclerosis	3.44e-05	5.49e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTGS2—atherosclerosis	3.44e-05	5.49e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MAPK3—atherosclerosis	3.43e-05	5.48e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—SERPINE1—atherosclerosis	3.4e-05	5.43e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AGER—atherosclerosis	3.37e-05	5.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NCF1—atherosclerosis	3.36e-05	5.37e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CD36—atherosclerosis	3.35e-05	5.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PRKCG—atherosclerosis	3.34e-05	5.34e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—TGFB1—atherosclerosis	3.33e-05	5.32e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—APOB—atherosclerosis	3.32e-05	5.31e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—NOS3—atherosclerosis	3.31e-05	5.29e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NOS2—atherosclerosis	3.29e-05	5.26e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTGS2—atherosclerosis	3.28e-05	5.24e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CG—atherosclerosis	3.27e-05	5.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD36—atherosclerosis	3.26e-05	5.22e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NOS3—atherosclerosis	3.24e-05	5.19e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—IL6—atherosclerosis	3.23e-05	5.17e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—STAT3—atherosclerosis	3.2e-05	5.12e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—STAT3—atherosclerosis	3.2e-05	5.12e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—MTHFR—atherosclerosis	3.17e-05	5.08e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EDNRA—atherosclerosis	3.17e-05	5.07e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCR2—atherosclerosis	3.17e-05	5.07e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—LPL—atherosclerosis	3.17e-05	5.07e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CYBA—atherosclerosis	3.16e-05	5.05e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PPARG—atherosclerosis	3.16e-05	5.05e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PPARA—atherosclerosis	3.11e-05	4.98e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—INS—atherosclerosis	3.1e-05	4.95e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PLAT—atherosclerosis	3.09e-05	4.94e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PARP1—atherosclerosis	3.09e-05	4.94e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GHRL—atherosclerosis	3.09e-05	4.94e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PRKCG—atherosclerosis	3.08e-05	4.93e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MAPK3—atherosclerosis	3.06e-05	4.89e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MAPK3—atherosclerosis	3.06e-05	4.89e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—STAT3—atherosclerosis	3.05e-05	4.88e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTGS2—atherosclerosis	3.02e-05	4.84e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AGT—atherosclerosis	3.02e-05	4.82e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—INS—atherosclerosis	3.01e-05	4.82e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PDGFB—atherosclerosis	3.01e-05	4.81e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—AKT1—atherosclerosis	2.98e-05	4.77e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—TGFB1—atherosclerosis	2.97e-05	4.74e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—TGFB1—atherosclerosis	2.97e-05	4.74e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTGS2—atherosclerosis	2.97e-05	4.74e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—APOE—atherosclerosis	2.96e-05	4.73e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—IL6—atherosclerosis	2.95e-05	4.72e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CRP—atherosclerosis	2.94e-05	4.7e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—NFKB1—atherosclerosis	2.94e-05	4.7e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CAV1—atherosclerosis	2.93e-05	4.68e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—APOA1—atherosclerosis	2.92e-05	4.67e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MAPK3—atherosclerosis	2.92e-05	4.66e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MAPK8—atherosclerosis	2.89e-05	4.62e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MTHFR—atherosclerosis	2.85e-05	4.56e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—ALB—atherosclerosis	2.84e-05	4.54e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—TGFB1—atherosclerosis	2.83e-05	4.52e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—NFKB1—atherosclerosis	2.82e-05	4.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—TLR4—atherosclerosis	2.82e-05	4.51e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—STAT3—atherosclerosis	2.82e-05	4.5e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PDGFB—atherosclerosis	2.78e-05	4.44e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SERPINE1—atherosclerosis	2.77e-05	4.43e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—AKT1—atherosclerosis	2.72e-05	4.35e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—NOS3—atherosclerosis	2.72e-05	4.34e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KNG1—atherosclerosis	2.71e-05	4.34e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ICAM1—atherosclerosis	2.7e-05	4.32e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AGTR1—atherosclerosis	2.7e-05	4.31e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—IL6—atherosclerosis	2.7e-05	4.31e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—IL6—atherosclerosis	2.7e-05	4.31e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MAPK3—atherosclerosis	2.69e-05	4.3e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CG—atherosclerosis	2.67e-05	4.26e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—APOE—atherosclerosis	2.66e-05	4.25e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NOS3—atherosclerosis	2.64e-05	4.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CAV1—atherosclerosis	2.63e-05	4.21e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PLG—atherosclerosis	2.63e-05	4.2e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—APOA1—atherosclerosis	2.63e-05	4.2e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—TGFB1—atherosclerosis	2.61e-05	4.18e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PPARG—atherosclerosis	2.57e-05	4.12e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—INS—atherosclerosis	2.52e-05	4.04e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MAPK3—atherosclerosis	2.52e-05	4.03e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—IL6—atherosclerosis	2.51e-05	4.01e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SOCS3—atherosclerosis	2.49e-05	3.98e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—AKT1—atherosclerosis	2.49e-05	3.98e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—AKT1—atherosclerosis	2.49e-05	3.98e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTGS2—atherosclerosis	2.48e-05	3.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOS2—atherosclerosis	2.48e-05	3.96e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTGS2—atherosclerosis	2.42e-05	3.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP3—atherosclerosis	2.41e-05	3.85e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF2—atherosclerosis	2.39e-05	3.83e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APOB—atherosclerosis	2.32e-05	3.72e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ALB—atherosclerosis	2.31e-05	3.7e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—STAT3—atherosclerosis	2.31e-05	3.7e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—AKT1—atherosclerosis	2.31e-05	3.7e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EDN1—atherosclerosis	2.29e-05	3.66e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—AKT1—atherosclerosis	2.28e-05	3.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCL5—atherosclerosis	2.27e-05	3.63e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—INS—atherosclerosis	2.27e-05	3.63e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—IL6—atherosclerosis	2.24e-05	3.57e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—IL6—atherosclerosis	2.24e-05	3.57e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—LPL—atherosclerosis	2.22e-05	3.55e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—NOS3—atherosclerosis	2.21e-05	3.54e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MAPK3—atherosclerosis	2.21e-05	3.53e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PRKCG—atherosclerosis	2.16e-05	3.45e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TGFB1—atherosclerosis	2.14e-05	3.43e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—IL6—atherosclerosis	2.13e-05	3.41e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SPP1—atherosclerosis	2.1e-05	3.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SERPINE1—atherosclerosis	2.08e-05	3.33e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—AKT1—atherosclerosis	2.08e-05	3.33e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—AKT1—atherosclerosis	2.08e-05	3.33e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—AKT1—atherosclerosis	2.06e-05	3.3e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—AKT1—atherosclerosis	2.06e-05	3.3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IFNG—atherosclerosis	2.06e-05	3.29e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS2—atherosclerosis	2.02e-05	3.24e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOS3—atherosclerosis	1.99e-05	3.18e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—IL6—atherosclerosis	1.97e-05	3.15e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—AKT1—atherosclerosis	1.97e-05	3.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PDGFB—atherosclerosis	1.95e-05	3.11e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—AKT1—atherosclerosis	1.94e-05	3.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AGT—atherosclerosis	1.9e-05	3.04e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—STAT3—atherosclerosis	1.89e-05	3.02e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APOE—atherosclerosis	1.86e-05	2.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—LEP—atherosclerosis	1.86e-05	2.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—IL6—atherosclerosis	1.84e-05	2.95e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CAV1—atherosclerosis	1.84e-05	2.95e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APOA1—atherosclerosis	1.84e-05	2.94e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL1B—atherosclerosis	1.83e-05	2.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTGS2—atherosclerosis	1.82e-05	2.91e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—AKT1—atherosclerosis	1.82e-05	2.9e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MAPK3—atherosclerosis	1.8e-05	2.88e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ESR1—atherosclerosis	1.78e-05	2.84e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—F2—atherosclerosis	1.75e-05	2.81e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TGFB1—atherosclerosis	1.75e-05	2.79e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—AKT1—atherosclerosis	1.73e-05	2.76e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—AKT1—atherosclerosis	1.73e-05	2.76e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NFKB1—atherosclerosis	1.71e-05	2.74e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—AKT1—atherosclerosis	1.7e-05	2.72e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MAPK8—atherosclerosis	1.68e-05	2.69e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CG—atherosclerosis	1.68e-05	2.68e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—AKT1—atherosclerosis	1.65e-05	2.63e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—AKT1—atherosclerosis	1.63e-05	2.61e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—IL6—atherosclerosis	1.62e-05	2.58e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—INS—atherosclerosis	1.59e-05	2.54e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCL2—atherosclerosis	1.56e-05	2.5e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—STAT3—atherosclerosis	1.54e-05	2.46e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF1—atherosclerosis	1.54e-05	2.46e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—AKT1—atherosclerosis	1.52e-05	2.43e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—AKT1—atherosclerosis	1.49e-05	2.38e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MAPK3—atherosclerosis	1.47e-05	2.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SERPINE1—atherosclerosis	1.46e-05	2.33e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—STAT3—atherosclerosis	1.42e-05	2.27e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOS3—atherosclerosis	1.39e-05	2.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MAPK3—atherosclerosis	1.36e-05	2.17e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IL6—atherosclerosis	1.32e-05	2.11e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TGFB1—atherosclerosis	1.32e-05	2.1e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AKT1—atherosclerosis	1.25e-05	2e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCL8—atherosclerosis	1.24e-05	1.98e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT1—atherosclerosis	1.22e-05	1.94e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP9—atherosclerosis	1.12e-05	1.79e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NFKB1—atherosclerosis	1.11e-05	1.77e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAPK8—atherosclerosis	1.09e-05	1.74e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL6—atherosclerosis	1.07e-05	1.72e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AKT1—atherosclerosis	1.02e-05	1.63e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—atherosclerosis	1e-05	1.61e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STAT3—atherosclerosis	9.94e-06	1.59e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IL6—atherosclerosis	9.92e-06	1.59e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT1—atherosclerosis	9.91e-06	1.58e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAPK3—atherosclerosis	9.5e-06	1.52e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TGFB1—atherosclerosis	9.22e-06	1.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT1—atherosclerosis	9.15e-06	1.46e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL6—atherosclerosis	6.94e-06	1.11e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT1—atherosclerosis	6.41e-06	1.02e-05	CbGpPWpGaD
